Abstract
A number of 46 out of a total of more than 200 recent patents in soft nanotechnology referring to applications of nanoemulsions for pharmaceutical and cosmetical formulations has been selected and reviewed. As key factors to maximize the efficiency of bioactive principles embedded within colloidal drug delivery systems are the nature and ratio of hydrophilic/lipophilic components, of surfactants/cosurfactants as emulsifiers, their mutual solubility and biocompatibility, the size and polydispersity of nanoparticles. The antioxidant and immunostimulative actions are discussed in relation to the specific therapeutic effects of galenical compositions used for preventing and/or treating various diseases.
Keywords: Nanoemulsions, microemulsions, solid lipid nanoparticles, antioxidant, immunostimulative activity
Recent Patents on Nanotechnology
Title: Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities
Volume: 2 Issue: 2
Author(s): Aurelia Meghea
Affiliation:
Keywords: Nanoemulsions, microemulsions, solid lipid nanoparticles, antioxidant, immunostimulative activity
Abstract: A number of 46 out of a total of more than 200 recent patents in soft nanotechnology referring to applications of nanoemulsions for pharmaceutical and cosmetical formulations has been selected and reviewed. As key factors to maximize the efficiency of bioactive principles embedded within colloidal drug delivery systems are the nature and ratio of hydrophilic/lipophilic components, of surfactants/cosurfactants as emulsifiers, their mutual solubility and biocompatibility, the size and polydispersity of nanoparticles. The antioxidant and immunostimulative actions are discussed in relation to the specific therapeutic effects of galenical compositions used for preventing and/or treating various diseases.
Export Options
About this article
Cite this article as:
Meghea Aurelia, Pharmaceuticals and Cosmeceuticals Based on Soft Nanotechnology Techniques with Antioxidative, Immunostimulative and other Therapeutic Activities, Recent Patents on Nanotechnology 2008; 2 (2) . https://dx.doi.org/10.2174/187221008784534541
DOI https://dx.doi.org/10.2174/187221008784534541 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Investigation of the Metal Bonding Properties of Some ARA-II Compounds Using Spectrofluorimetric Method
Current Drug Therapy subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders Mechanisms of Tau Self-Aggregation and Neurotoxicity
Current Alzheimer Research VEGF Signaling Regulates Cofilin and the Arp2/3-complex within the Axonal Growth Cone
Current Neurovascular Research The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases
Current Molecular Pharmacology Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Current Pharmaceutical Biotechnology CHIP Knockdown Reduced Heat Shock Response and Protein Quality Control Capacity in Lens Epithelial Cells
Current Molecular Medicine The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders
Current Pharmaceutical Design Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer’s Disease
Current Alzheimer Research Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
Recent Patents on CNS Drug Discovery (Discontinued) Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Current Protein & Peptide Science Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
Current Genomics Design and Development of Novel Transdermal Nanoemulgel for Alzheimer’s Disease: Pharmacokinetic, Pharmacodynamic and Biochemical Investigations
Current Drug Delivery FDG PET/MR Imaging in Major Neurocognitive Disorders
Current Alzheimer Research Current Scenario of 1,4-Diazepines as Potent Biomolecules-A Mini Review
Mini-Reviews in Medicinal Chemistry Acetylcholinesterase Inhibitor Donepezil Effects on Plasma β-Hydroxybutyrate Levels in the Treatment of Alzheimer’s Disease
Current Alzheimer Research